Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061

导出原文传递

翻译打印收藏纠错

作者： Cerbone, Linda ^[1] ; Sternberg, Cora N. ^[2] ; Sengelov, Lisa ^[3] ; Agerbaek, Mads ^[4] ; Van Herpen, Carla ^[5] ; Marreaud, Sandrine ^[6] ; Collette, Sandra ^[7] ; Zhang, Jianping ; Daugaard, Gedske

作者单位： Herlev Hosp, DK-2730 Herlev, Denmark ^[1] EORTC Headquarters, Brussels, Belgium ^[2] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark ^[3] San Camillo & Forlanini Hosp, Dept Med Oncol, Rome, Italy ^[4] GlaxoSmithKline, Res Triangle Pk, NC USA ^[5] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands ^[6] Rigshosp, DK-2100 Copenhagen, Denmark ^[7]

关键词 Bladder cancer Combination therapy Lapatinib Phase I Chemotherapy Metastasis

发布时间 2017-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交